KZ Precision Corporation (KOSDAQ:036560)
13,850
-90 (-0.65%)
At close: Feb 13, 2026
KZ Precision Market Cap
KZ Precision has a market cap or net worth of 220.19 billion as of February 19, 2026. Its market cap has increased by 11.48% in one year.
Market Cap
220.19B
Enterprise Value
203.56B
Revenue
116.71B
Ranking
n/a
PE Ratio
19.79
Stock Price
13,850.00
Market Cap Chart
Since January 22, 2001, KZ Precision's market cap has increased from 15.44B to 220.19B, an increase of 1,326.53%. That is a compound annual growth rate of 11.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 218.14B | -8.10% |
| Dec 30, 2025 | 237.35B | 20.18% |
| Dec 30, 2024 | 197.51B | -1.49% |
| Dec 28, 2023 | 200.50B | 6.97% |
| Dec 29, 2022 | 187.43B | 31.35% |
| Dec 30, 2021 | 142.70B | 11.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangsin Energy Display Precision | 220.98B |
| DNF Co.,Ltd. | 220.62B |
| AptaBio Therapeutics | 220.53B |
| Telechips | 220.24B |
| ISU Abxis | 219.90B |
| CYMECHS | 219.03B |
| GC Genome | 218.53B |
| Vaxcell-Bio Therapeutics | 217.69B |